FOXA1 is a determinant of drug resistance in breast cancer cells

PURPOSE: Breast cancer is one of the most commonly diagnosed cancers in women. Five subtypes of breast cancer differ in their genetic expression profiles and carry different prognostic values, with no treatments available for some types, such as triple-negative, due to the absence of genetic signatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Uttom, Ardasheva, Anastasia, Mahmud, Zimam, Coombes, R. Charles, Yagüe, Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990828/
https://www.ncbi.nlm.nih.gov/pubmed/33417085
http://dx.doi.org/10.1007/s10549-020-06068-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990828/
https://www.ncbi.nlm.nih.gov/pubmed/33417085
http://dx.doi.org/10.1007/s10549-020-06068-5

Ejemplares similares